Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 3Unknown 2Withdrawn 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

CNS 2Thoracic 1

Conditions

Carcinoma, Non-Small-Cell Lung 13Carcinoma, Hepatocellular 6Neoplasm Metastasis 5Neoplasms 3Squamous Cell Carcinoma of Head and Neck 2Recurrence 2Lung Neoplasms 2Cholangiocarcinoma 2Brain Neoplasms 2Uveal Melanoma 1Triple Negative Breast Neoplasms 1Stomach Neoplasms 1Small Cell Lung Carcinoma 1Sarcopenia 1Rectal Neoplasms 1Radiation Pneumonitis 1Pancreatic Neoplasms 1Pancreatic Ductal Adenocarcinoma 1Ovarian Neoplasms 1Oropharyngeal Neoplasms 1Objective Response Rate 1Neoplasm, Residual 1Multiple Myeloma 1Melanoma 1Lymphoma 1Locally Advanced Non-small Cell Lung Cancer 1Head and Neck Neoplasms 1Gallbladder Neoplasms 1Deglutition Disorders 1Colorectal Neoplasms 1

Interventions

Radiosurgery 12Temozolomide 10Radiotherapy 10Magnetic Resonance Spectroscopy 7Erlotinib Hydrochloride 6Bevacizumab 6Surgical Procedures, Operative 5Pemetrexed 5Gefitinib 5Drug Therapy 5Carboplatin 5pyrotinib 4icotinib 4aumolertinib 4Trastuzumab 3Spermine Synthase 3Radiation 3Lomustine 3Etoposide 3Dexmedetomidine 3Chlorotoxin 3Carmustine 3osimertinib 2camrelizumab 2apatinib 2Tyrosine Kinase Inhibitors 2Thiotepa 2Surveys and Questionnaires 2Sevoflurane 2Propofol 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Brain Neoplasms × Immunotherapy × Clear all
NCT03458455 2023-11-01

TREATMENT

Oslo University Hospital

Unknown
200 enrolled
CNS

Brain Neoplasms

NCT04291092 2021-09-10

Camrelizumab Combined With Local Treatment in NSCLC Patients With BM

Zhejiang Cancer Hospital

Phase 2 Unknown
63 enrolled
CNSThoracic

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡